.Merck defeats revenues requirements, raises purchases expectation on powerful need for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Earnings Estimates as Keytruda Sales Growth BloombergMerck Sell: Pharma Titan Posts Powerful Results, However Overview Falls Short Entrepreneur's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps revenue and purchases assumptions amidst Keytruda strong point, however delivers blended full-year outlook MarketWatch.